PC(o-18:1(11Z)/18:2(9Z,12Z))

Metabolite details

Identifier

KBRIWDRDGVERBB-VXKJXORPSA-N

InChI Key

KBRIWDRDGVERBB-VXKJXORPSA-N

IUPAC name

Preferred name

PC(o-18:1(11Z)/18:2(9Z,12Z))

INN name

—

Synonym

trimethyl(2-{[(2R)-3-[(11Z)-octadec-11-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)azanium

ChEBI

CHEBI:89879

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_OXPA_Treatment